Y36-99481-75154 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-27
Registered in v-safe
2021-02-27
Dose 1 — Pfizer-BioNTech
2021-02-27
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-02-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-03-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-06
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-03-13
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-20
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-03-21
Dose 2 — Pfizer-BioNTech
2021-03-21
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-28
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-04
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-11
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-18
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-25
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-02
Survey response — day 42, dose 2
MedDRA: Deafness, Tinnitus — Feeling: Poor · Be unable to do your normal daily activities

Free text: Tinnitus and bilateral hearing loss, improving with steroids.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-20
Survey response — 3 months, dose 2
MedDRA: Cardiac stress test abnormal, Deafness, Hospitalisation, Myocardial necrosis marker increased, Myocarditis, Office visit, Tinnitus — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Myocarditis with abnormal stress test and elevated cardiac enzymes. Tinnitus with hearing loss. This required hospitalization and 2 ENT consultations, one at Ma(b)(6) yo. Its cost me over $5000 so far. Please educate doctors on these side effects.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2022-03-21
Survey response — 12 months, dose 2
MedDRA: Chest pain, Palpitations, Tinnitus — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Chest pain, palpitations, and tinnitus. This reporting system is a joke and there appears to have been a coordinated effort to downplay both the side effects and inadequacy of the vaccine. There is an autoimmune attack on ACE-2 receptors like GBS.

MedDRA releases: 2024-11 · check-in free text available
2022-03-21
Report sent to call center — 12 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-03-23
Call 1 — Left Voicemail
2022-03-29
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-27	Pfizer-BioNTech
2	2021-03-21	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-03-21	Successful 2022-03-29	Participant prefers to complete VAERS report online

Free text

Release 8 — day 42, dose 2

2021-05-02

Symptoms: Tinnitus and bilateral hearing loss, improving with steroids.

Release 9 — 3 months, dose 2

2021-06-20

Symptoms: Myocarditis with abnormal stress test and elevated cardiac enzymes. Tinnitus with hearing loss. This required hospitalization and 2 ENT consultations, one at Ma(b)(6) yo. Its cost me over $5000 so far. Please educate doctors on these side effects.

redacted (b)(6)

Release 11 — 12 months, dose 2

2022-03-21

Symptoms: Chest pain, palpitations, and tinnitus. This reporting system is a joke and there appears to have been a coordinated effort to downplay both the side effects and inadequacy of the vaccine. There is an autoimmune attack on ACE-2 receptors like GBS.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cardiac stress test abnormal	✓	✓	✓
SD	Chest pain	·	·	✓
SD	Deafness	✓	✓	✓
SD	Hospitalisation	✓	✓	✓
SD	Myocardial necrosis marker increased	✓	✓	✓
SD	Myocarditis	✓	✓	✓
SD	Office visit	✓	✓	✓
SD	Palpitations	·	·	✓
SD	Tinnitus	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release